Cancer Associated Thrombosis Cat Clinical Trials

ReadTheTrial indexes 1 studies for Cancer Associated Thrombosis Cat. The most common development stage is Phase 3 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

1 clinical trials found for Cancer Associated Thrombosis Cat.

Pipeline by Phase

PhaseTrialsDistribution
Phase 3 1
100%

Trial Status Breakdown

Trials for Cancer Associated Thrombosis Cat

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess Efficacy and Safety of REGN7508, a Monoclonal Antibody Against FXI, for Primary Prophylaxis of Cancer-Associated Thrombosis for Participants With Solid Tumors Undergoing Cancer Treatment (ROXI-CAT-I)

NCT07410117 · RECRUITING · Phase 3

Frequently Asked Questions

What clinical trials are available for Cancer Associated Thrombosis Cat?

There are 1 clinical trials listed for Cancer Associated Thrombosis Cat. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Cancer Associated Thrombosis Cat trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Cancer Associated Thrombosis Cat trials in?

Current Cancer Associated Thrombosis Cat trials are distributed across: Phase 3 (1).

Find More Trials